======= ANAPC5 ======= == Gene Information == * **Official Symbol**: ANAPC5 * **Official Name**: anaphase promoting complex subunit 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51433|51433]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UJX4|Q9UJX4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANAPC5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANAPC5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606948|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. {ECO:0000269|PubMed:18485873}. |Apc5| |positive regulation of mitotic sister chromatid separation| |positive regulation of mitotic metaphase/anaphase transition| |positive regulation of metaphase/anaphase transition of cell cycle| |positive regulation of chromosome separation| |positive regulation of mitotic sister chromatid segregation| |anaphase-promoting complex| |positive regulation of chromosome segregation| |protein K11-linked ubiquitination| |regulation of mitotic metaphase/anaphase transition| |positive regulation of mitotic nuclear division| |regulation of metaphase/anaphase transition of cell cycle| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |positive regulation of nuclear division| |regulation of mitotic sister chromatid segregation| |positive regulation of mitotic cell cycle phase transition| |regulation of sister chromatid segregation| |anaphase-promoting complex-dependent catabolic process| |protein phosphatase binding| |positive regulation of cell cycle phase transition| |regulation of chromosome segregation| |positive regulation of mitotic cell cycle| |regulation of mitotic nuclear division| |positive regulation of chromosome organization| |regulation of nuclear division| |ubiquitin protein ligase activity| |positive regulation of cell cycle process| |protein polyubiquitination| |proteasome-mediated ubiquitin-dependent protein catabolic process| |regulation of chromosome organization| |proteasomal protein catabolic process| |positive regulation of cell cycle| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |cell division| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |positive regulation of organelle organization| |regulation of mitotic cell cycle| |protein catabolic process| |protein ubiquitination| |regulation of cell cycle process| |protein modification by small protein conjugation| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of cell cycle| |positive regulation of cellular component organization| |proteolysis| |regulation of organelle organization| |cell cycle| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 269/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|9/28| |blood|14/28| |bone|8/26| |breast|13/33| |central nervous system|20/56| |cervix|0/4| |colorectal|6/17| |esophagus|4/13| |fibroblast|0/1| |gastric|7/16| |kidney|5/21| |liver|7/20| |lung|24/75| |lymphocyte|6/16| |ovary|10/26| |pancreas|8/24| |peripheral nervous system|8/16| |plasma cell|4/15| |prostate|1/1| |skin|9/24| |soft tissue|5/9| |thyroid|0/2| |upper aerodigestive|8/22| |urinary tract|8/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 632 * **Expression level (log2 read counts)**: 8.29 {{:chemogenomics:nalm6 dist.png?nolink |}}